Weighted Average Number of Shares Outstanding, Diluted of NEPHROS INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
NEPHROS INC quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • NEPHROS INC Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 10,968,063, a 3.5% increase year-over-year.
  • NEPHROS INC annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 10,968,063, a 3.5% increase from 2024.
  • NEPHROS INC annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 10,602,004, a 2.1% increase from 2023.
  • NEPHROS INC annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 10,386,018, a 0.86% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

NEPHROS INC Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 10,968,063 +366,059 +3.5% 01 Oct 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 11,040,925 +460,019 +4.3% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 10,813,028 +303,091 +2.9% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 10,615,766 +113,995 +1.1% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 10,602,004 +215,986 +2.1% 01 Oct 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 10,580,906 +120,040 +1.1% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 10,509,937 +212,508 +2.1% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 10,501,771 +204,342 +2% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 10,386,018 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 10,460,866 +157,048 +1.5% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 10,297,429 -1,719 -0.02% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 10,297,429 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q3 2022 10,303,818 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 10,299,148 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q2 2016 48,545,720 +17,355,006 +56% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 48,173,521 +11,091,022 +30% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2016 2016 Q1
Q3 2015 32,622,377 -868,812 -2.6% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2015 2015 Q3
Q2 2015 31,190,714 +6,023,962 +24% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2
Q1 2015 37,082,499 +18,265,753 +97% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016 2016 Q1
Q4 2014 23,817,184 01 Oct 2014 31 Dec 2014 10-K 15 Apr 2015 2014 FY
Q3 2014 33,491,189 01 Jul 2014 30 Sep 2014 10-Q 10 Nov 2015 2015 Q3
Q2 2014 25,166,752 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015 2015 Q2
Q1 2014 18,816,746 +1,183,386 +6.7% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q1 2013 17,633,360 01 Jan 2013 31 Mar 2013 10-K 15 Apr 2015 2014 FY

NEPHROS INC Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 10,968,063 +366,059 +3.5% 01 Jan 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
2024 10,602,004 +215,986 +2.1% 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
2023 10,386,018 +88,884 +0.86% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
2022 10,297,134 01 Jan 2022 31 Dec 2022 10-K 15 Mar 2024 2023 FY
2014 23,817,184 +3,056,774 +15% 01 Jan 2014 31 Dec 2014 10-K 15 Apr 2015 2014 FY
2013 20,760,410 01 Jan 2013 31 Dec 2013 10-K 15 Apr 2015 2014 FY
2010 2,087,068 01 Jan 2010 31 Dec 2010 10-K 15 Apr 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.